Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives

Neurology Research International
Osama A Khairoalsindi, Ahmad R Abuzinadah

Abstract

Amyotrophic lateral sclerosis is a neurodegenerative disease that leads to loss of the upper and lower motor neurons. Almost 90% of all cases occur in the sporadic form, with the rest occurring in the familial form. The disease has a poor prognosis, with only two disease-modifying drugs approved by the United States Food and Drug Administration (FDA). The approved drugs for the disease have very limited survival benefits. Edaravone is a new FDA-approved medication that may slow the disease progression by 33% in a selected subgroup of ALS patients. This paper covers the various interventions that may provide survival benefits, such as early diagnosis, medications, gene therapy, stem cell therapy, diet, nutritional supplements, multidisciplinary clinics, and mechanical invasive and noninvasive ventilation. The recent data on masitinib, the role of enteral feeding, gene therapy, and stem cell therapy is discussed.

References

Jun 1, 1994·Journal of the Neurological Sciences·T ShimizuM Oda
May 1, 1997·Archives of Neurology·C R Reider, G W Paulson
Jun 29, 1999·Journal of the Neurological Sciences·K A KleopaT Heiman-Patterson
Jul 24, 2001·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·B R BrooksUNKNOWN World Federation of Neurology Research Group on Motor Neuron Diseases
Jul 24, 2001·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·C DesnuelleA Favier
Jun 14, 2002·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·M R TurnerA Al-Chalabi
Jul 10, 2002·Neurology·A ChiòUNKNOWN Piemonte and Valle d'Aosta Register for ALS (PARALS)
Mar 12, 2003·Neurology·M A del AguilaG van Belle
Jul 9, 2003·Neurology·Hideaki Hayashi, Edward Anthony Oppenheimer
Aug 23, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·B J TraynorO Hardiman
Oct 26, 2005·Neurology·J P Van den BergL H Van den Berg
Apr 15, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·A ChiòUNKNOWN PARALS
Aug 1, 2006·The Journal of Clinical Investigation·Richard A SmithDon W Cleveland
Aug 10, 2006·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·A GalbusseraG Filippini
Nov 28, 2006·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Hiide Yoshino, Akio Kimura
Jul 27, 2007·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Peter Munch AndersenUNKNOWN EALSC Working Group
Oct 10, 2007·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Philippe CorciaVincent Meininger
Feb 5, 2009·Orphanet Journal of Rare Diseases·Lokesh C Wijesekera, P Nigel Leigh
Sep 19, 2009·Practical Neurology·Kevin Talbot
May 14, 2010·Arquivos de neuro-psiquiatria·Luciano Bruno de Carvalho SilvaJaime Amaya-Farfán
Jul 28, 2010·Journal of Neurology, Neurosurgery, and Psychiatry·A ChiòUNKNOWN PARALS
Aug 3, 2010·Journal of the Neurological Sciences·Nadège LimousinJulien Praline
Nov 3, 2010·Lancet Neurology·Luc DupuisJean-Philippe Loeffler
Nov 5, 2010·Journal of Neurology, Neurosurgery, and Psychiatry·Susan ByrneOrla Hardiman
Nov 18, 2010·Journal of Neurology·Orla Hardiman
Nov 26, 2010·Journal of Neurology, Neurosurgery, and Psychiatry·B MarinP Couratier

❮ Previous
Next ❯

Citations

May 31, 2019·International Journal of Molecular Sciences·Natalia NowickaJoanna Wojtkiewicz
May 30, 2020·International Journal of Molecular Sciences·Serena StangaAlessandro Vercelli
Nov 28, 2020·Brain and Behavior·Ahmad R AbuzinadahMohammed H Alanazy
Feb 23, 2021·Medical Acupuncture·Erik K Koda
Aug 28, 2020·Neurochemistry International·Dia AdvaniPravir Kumar
Jul 9, 2020·Journal of Cardiovascular Pharmacology·Zoltán PappPiero Pollesello
Mar 22, 2021·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Kathryn Russo, Kristi A Wharton
Jun 3, 2021·Journal of Personalized Medicine·Kevin PeikertAndreas Hermann

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligonucleotide

Clinical Trials Mentioned

NCT02588677

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Related Papers

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Antonio M EsquinasGiuseppe Francesco Sferrazza Papa
Advances in Experimental Medicine and Biology
F H Norris, E H Denys
© 2022 Meta ULC. All rights reserved